Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated Hepatitis A Vaccine in Korean Healthy Children
NCT03654664Phase 3Completed
- Sponsor
- Boryung
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hepatitis A vaccine inactivated in hepatitis A (HAV) (2 arms), sponsored by Boryung. Primary endpoint: Seroconversion rate. Started Jun 2017; status: completed.
02
Drugs
hepatitis A vaccine inactivated
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT03654664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03654664.